---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-000270"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T17:52:29.649609+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals grants 30,000 stock options each to CEO, CFO, COO and directors

## Summary
- Annual grant of stock options to employees, executive officers, and directors on January 14, 2022.
- Exercise price set at $4.57 per share, based on closing price on grant date.
- Options vest in three equal tranches at 6, 18, and 30 months; full vesting upon change of control.
- CEO Amy Trombly, CFO Jerry Dvonch, and COO Bruce Thornton each received 30,000 options.
- Each director also received 30,000 options.

## SEC filing metadata
- accession: 0001683168-22-000270
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316822000270/0001683168-22-000270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316822000270/snoa_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-000270
- JSON: https://secwatch.observer/filing/0001683168-22-000270.json
- Plain text: https://secwatch.observer/filing/0001683168-22-000270.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.